Optomed Oyj
HEL:OPTOMED.HE
3.16 (EUR) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|
Revenue
| 15.1 | 14.66 | 14.85 | 13.011 | 14.977 | 14.463 | 6.899 | 6.609 |
Cost of Revenue
| 4.857 | 5.448 | 5.102 | 4.213 | 5.286 | 4.954 | 3.118 | 2.99 |
Gross Profit
| 10.243 | 9.212 | 9.748 | 8.798 | 9.691 | 9.509 | 3.781 | 3.619 |
Gross Profit Ratio
| 0.678 | 0.628 | 0.656 | 0.676 | 0.647 | 0.657 | 0.548 | 0.548 |
Reseach & Development Expenses
| 0.23 | 0.361 | 0.412 | 0.276 | 0.356 | 1.072 | 0.227 | 0.532 |
General & Administrative Expenses
| 2.509 | 0.765 | 0.866 | 0.714 | 0.504 | 1.65 | 0.22 | 0.251 |
Selling & Marketing Expenses
| 0.635 | 0.784 | 0.674 | 0.422 | 0.489 | 0.509 | 0.647 | 0.648 |
SG&A
| 3.144 | 1.549 | 1.54 | 1.136 | 0.993 | 2.159 | 0.867 | 0.899 |
Other Expenses
| 0.049 | 11.973 | 12.168 | 10.131 | 10.552 | 10.174 | 5.515 | 4.82 |
Operating Expenses
| 14.217 | 13.883 | 14.12 | 11.543 | 11.901 | 10.174 | 6.609 | 6.251 |
Operating Income
| -3.974 | -4.671 | -4.372 | -2.745 | -2.21 | -0.665 | -2.827 | -2.611 |
Operating Income Ratio
| -0.263 | -0.319 | -0.294 | -0.211 | -0.148 | -0.046 | -0.41 | -0.395 |
Total Other Income Expenses Net
| -0.545 | -0.88 | 0.045 | -0.502 | -0.742 | -0.783 | -0.062 | -0.13 |
Income Before Tax
| -4.519 | -5.551 | -4.327 | -3.247 | -2.952 | -1.221 | -2.89 | -2.762 |
Income Before Tax Ratio
| -0.299 | -0.379 | -0.291 | -0.25 | -0.197 | -0.084 | -0.419 | -0.418 |
Income Tax Expense
| -0.079 | -0.079 | -0.078 | -0.07 | -0.077 | 0.048 | -0.003 | -0.003 |
Net Income
| -4.441 | -5.472 | -4.249 | -3.177 | -2.875 | -1.268 | -2.887 | -2.758 |
Net Income Ratio
| -0.294 | -0.373 | -0.286 | -0.244 | -0.192 | -0.088 | -0.418 | -0.417 |
EPS
| -0.27 | -0.37 | -0.32 | -0.24 | -0.32 | -0.096 | -0.22 | -0.21 |
EPS Diluted
| -0.27 | -0.37 | -0.32 | -0.24 | -0.32 | -0.096 | -0.22 | -0.21 |
EBITDA
| -1.302 | -1.251 | -0.966 | -0.743 | -0.317 | 1.372 | -1.65 | -1.905 |
EBITDA Ratio
| -0.086 | -0.085 | -0.065 | -0.057 | -0.021 | 0.095 | -0.239 | -0.288 |